These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 6150528)

  • 21. Endogenous hyperglycemia restores insulin release impaired by somatostatin analogue.
    Taborsky GJ; Porte D
    Am J Physiol; 1981 Apr; 240(4):E407-13. PubMed ID: 6111928
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Somatostatin antagonist analog increases GH, insulin, and glucagon release in the rat.
    Fries JL; Murphy WA; Sueiras-Diaz J; Coy DH
    Peptides; 1982; 3(5):811-4. PubMed ID: 6129618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth hormone secretion and pancreatic function following somatostatin infusion in ducks (Anas platyrhynchos).
    Strosser MT; Harvey S; Foltzer C; Mialhe P
    Br Poult Sci; 1985 Jul; 26(3):425-32. PubMed ID: 2862973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of the somatostatin analog D-Trp8,D-Cys14 on glucose insulin, pancreatic glucagon and growth hormone plasma levels in acromegalics and mild diabetics.
    Trovati M; Massara F; Camanni F; Molinatti GM; Lorenzati R; Pagano GF
    J Endocrinol Invest; 1980; 3(2):189-92. PubMed ID: 6104680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endocrine profile of a long-acting somatostatin derivative SMS 201-995. Study in normal volunteers following subcutaneous administration.
    del Pozo E; Neufeld M; Schlüter K; Tortosa F; Clarenbach P; Bieder E; Wendel L; Nüesch E; Marbach P; Cramer H
    Acta Endocrinol (Copenh); 1986 Apr; 111(4):433-9. PubMed ID: 2871684
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Somatostatin-induced changes in insulin and glucagon secretion in normal and diabetic dogs.
    Sakurai H; Dobbs R; Unger RH
    J Clin Invest; 1974 Dec; 54(6):1395-402. PubMed ID: 4436439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls.
    Steiger A; Guldner J; Hemmeter U; Rothe B; Wiedemann K; Holsboer F
    Neuroendocrinology; 1992 Oct; 56(4):566-73. PubMed ID: 1361964
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of the new somatostatin analogue (BIM 23014) on blood glucose homeostasis in normal men.
    Kuhn JM; Basin C; Mollard M; De Rouge B; Schatz B; Wolf LM
    Eur J Clin Invest; 1992 Dec; 22(12):793-9. PubMed ID: 1478250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increase by somatostatin of the arginine induced rise in blood glucose in untreated insulin requiring diabetics.
    Waldhäusl W; Bratusch-Marrain P; Nowotny P
    Endokrinologie; 1979; 73(3):323-7. PubMed ID: 499100
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE; Lorenzi M; Bier DM; Tsalikian E; Schneider V; Karam JH; Forsham PH
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methoscopolamine inhibition of sleep-related growth hormone secretion. Evidence for a cholinergic secretory mechanism.
    Mendelson WB; Sitaram N; Wyatt RJ; Gillin JC; Jacobs LS
    J Clin Invest; 1978 Jun; 61(6):1683-90. PubMed ID: 659621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal temporal patterns of glucose tolerance in obesity: relationship to sleep-related growth hormone secretion and circadian cortisol rhythmicity.
    Van Cauter EV; Polonsky KS; Blackman JD; Roland D; Sturis J; Byrne MM; Scheen AJ
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1797-805. PubMed ID: 7989487
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Plasma glucagon decreases during night-time sleep in Type 1 diabetic patients and healthy control subjects.
    Jauch-Chara K; Hallschmid M; Schmid SM; Oltmanns KM; Peters A; Born J; Schultes B
    Diabet Med; 2007 Jun; 24(6):684-7. PubMed ID: 17381498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of glucagon, catecholamines, and growth hormone in human glucose counterregulation. Effects of somatostatin and combined alpha- and beta-adrenergic blockade on plasma glucose recovery and glucose flux rates after insulin-induced hypoglycemia.
    Rizza RA; Cryer PE; Gerich JE
    J Clin Invest; 1979 Jul; 64(1):62-71. PubMed ID: 36413
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Entrainment of ultradian oscillations in the secretion of insulin and glucagon to the nonrapid eye movement/rapid eye movement sleep rhythm in humans.
    Kern W; Offenheuser S; Born J; Fehm HL
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1541-7. PubMed ID: 8636364
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A comparative study of metabolic and hormonal responses to somatostatin and propranolol in man.
    Giugliano D; Torella R; Sgambato S
    Acta Diabetol Lat; 1979; 16(1):77-81. PubMed ID: 452822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of growth hormone for blood glucose regulation following insulin-induced nocturnal hypoglycemia in insulin-dependent diabetes mellitus.
    Kollind M; Adamson U; Lins PE; Curstedt T
    Acta Med Scand; 1988; 223(2):159-64. PubMed ID: 2894751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatostatin blockade of acute and chronic stimuli of the endocrine pancreas and the consequences of this blockade on glucose homeostasis.
    Chideckel EW; Palmer J; Koerker DJ; Ensinck J; Davidson MB; Goodner CJ
    J Clin Invest; 1975 Apr; 55(4):754-62. PubMed ID: 804491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous positive airway pressure treatment. Effects on growth hormone, insulin and glucose profiles in obstructive sleep apnea patients.
    Saini J; Krieger J; Brandenberger G; Wittersheim G; Simon C; Follenius M
    Horm Metab Res; 1993 Jul; 25(7):375-81. PubMed ID: 8406324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitory effect of somatostatin-28 on pancreatic polypeptide, glucagon and insulin secretion in normal man.
    Marco J; Correas I; Zulueta MA; Vincent E; Coy DH; Comaru-Schally AM; Schally AV; Rodríguez-Arnao MD; Gómez-Pan A
    Horm Metab Res; 1983 Aug; 15(8):363-6. PubMed ID: 6137445
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.